Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
Gut2010Vol. 60(2), pp. 247–254
Citations Over TimeTop 1% of 2010 papers
Scott J. Patterson, Jacob George, Simone I. Strasser, A. U. Lee, William Sievert, Amanda Nicoll, P. V. Desmond, Stuart K. Roberts, S. Locarnini, S. Bowden, Peter Angus
Abstract
In heavily pretreated patients with a high rate of genotypic resistance, TDF retains significant activity against HBV although this appears diminished in comparison with studies of naïve patients.
Related Papers
- → Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir–lamivudine combination therapy(2005)19 cited
- → Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment(2008)7 cited
- → Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B(2008)3 cited
- Observation upon curative effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B(2011)
- Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B(2008)